NCT01845090

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23

Compared the Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 With Calcium Carbonate in Hemodialysis Patients

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Camillians Saint Mary's Hospital Luodong · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare the effect of lanthanum carbonate with calcium carbonate on serum FGF23 levels in hemodialysis patients.

Detailed description

The investigators enrolled patients on maintenance hemodialysis and randomized them to two groups. One group will receive lanthanum carbonate and another group will receive calcium carbonate. The investigators will compare serum FGF23 levels between two groups after they receive above medication for 6 months.

Conditions

• Other Nonspecific Abnormal Serum Enzyme Levels

Interventions

Type	Name	Description
DRUG	Lanthanum carbonate	the effect on serum FGF23
DRUG	Calcium Carbonate	Calcium carbonate 500mg\~1000 mg tid for 6 months

Timeline

• Start date: 2011-08-01
• Primary completion: 2014-07-01
• Completion: 2014-07-01
• First posted: 2013-05-03
• Last updated: 2013-05-03

Locations

1 site across 1 country: Taiwan